PTCE Pharmacy Connect | Pharmacy Times

Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty, and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education.

Best Practices for Management of Hyperlipidemia: A Focus on Guidelines and Patient Adherence

Educational Objectives

Examine best practices for optimizing medication adherence and treatment initiation in hypercholesterolemia management

Explain patient education and counseling for managing hypercholesteremia

Faculty:

Joseph Saseen, PharmD, BCPS, BCACP, CLS

Professor and Associate Dean for Clinical Affairs

University of Colorado Anschutz Medical Campus

Skaggs School of Pharmacy and Pharmaceutical Sciences

Aurora, Colorado

 

Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA

Executive Director, Ambulatory Pharmacy Services

Grady Health System

Atlanta, Georgia

Joseph Saseen, PharmD, BCPS, BCACP, CLS, has the following financial relationships with commercial interests to disclose:

Other Support (Lipid Monitoring Committee): Amgen (VESALIUS and OCEAN(a))

 

Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA, has the following financial relationships with commercial interests to disclose:

Grant/Research Support: Novartis

Consultant: Novartis, Regeneron

 

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-9999-25-069-H01-P. The activity is available for CE credit through March 31, 2026.

 

This activity is jointly provided by the University of Connecticut School of Pharmacy–Storrs and Pharmacy Times Continuing Education™, and is supported by an educational grant from Novartis Pharmaceuticals Corporation.

 

Please follow the link below to access this activity on PTCE and claim CE credit:

www.pharmacytimes.org/hyperlipidemiapodcast

Educational Objectives

Review recent clinical updates of RET inhibitors and how they fit into the treatment paradigm for non‒small cell lung cancer

Identify and manage adverse effects of RET inhibitors to ensure patient safety and improve adherence

 

Faculty

Lauren Ledbetter, PharmD, BCOP

Clinical Pharmacy Specialist, Thoracic Medical Oncology

The James Cancer Hospital at The Ohio State University

Columbus, Ohio

 

Moderator

Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA

Clinical Pharmacy Manager

University of Kansas Cancer Center

Division of Hematologic Malignancies & Cellular Therapeutics

 

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-24-304-H01-P. The activity is available for CE credit through October 31, 2025.

 

This activity is supported by an educational grant from Rigel Pharmaceuticals, Inc.

Educational Objectives

Review challenges that impact optimal treatment of skin barrier dysfunction in patients with acne who are seeking OTC care

List strategies to individualize patient care and improve recommendations for patients with acne experiencing skin barrier dysfunction

Faculty:

Robin Laird

Patient Advocate

Los Angeles, California

 
Mary Barna Bridgeman, PharmD, BCPS, BCGP

Clinical Professor

Ernest Mario School of Pharmacy

Rutgers, The State University of New Jersey

Piscataway, New Jersey

 

Internal Medicine Pharmacist

Robert Wood Johnson University Hospital-New Brunswick

New Brunswick, New Jersey

Mary Barna Bridgeman, PharmD, BCPS, BCGP, has no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Liza Patel, PharmD, RPh; Aleksandra Thomas; Susan Pordon; Brianna Winters; Chloe Taccetta; and Rebecca Green have no relevant financial relationships with commercial interests to disclose.

An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hour (0.05 CEU) under the ACPE universal activity numbers 0290-0000-24-128-H01-P and 0290-0000-24-128-H01-T. The activity is available for CE credit through April 29, 2025.

This activity is supported by an educational grant from CeraVe.

Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty, and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education.

Title: Challenges in Treatment of Desmoid Tumors and Managed Care Solutions

Educational Objectives

• Recall the key characteristics of desmoid tumors (DT), including presentation, frequency, genetic mutations, development, and outlook for individual patients
• Outline practical solutions to improve managed care-driven communication with health care providers and address the clinical and financial burden of unresectable, recurrent DT
Moderator:

Laura Bobolts, PharmD, BCOP

Senior Vice President of Clinical Strategy and Growth

OncoHealth

Plantation, Florida

 

Faculty:

Christy Harris, PharmD, BCOP, FHOPA    

Clinical Pharmacy Specialist                                                               

Dana-Farber Cancer Institute

Associate Professor

Massachusetts College of Pharmacy and Health Sciences

Boston, Massachusetts

 

Christy Harris, PharmD, BCOP, FHOPA and Laura Bobolts, PharmD, BCOP have no financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-0000-23-421-H01-P. The activity is available for CE credit through February 28, 2024.

This activity is supported by an educational grant from SpringWorks Therapeutics.

To claim CE credit for this activity, please follow this link: www.pharmacytimes.org/atopic-derm-podcast-630

Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty, and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education.

Educational Objectives

Review patient barriers that impact optimal treatment of patients with atopic dermatitis (AD) who are seeking OTC care

List strategies to individualize patient care and improve recommendations for AD

Moderator:

Mary Bridgeman, PharmD, BCPS, BCGP

Clinical Professor

Ernest Mario School of Pharmacy

Rutgers, The State University of New Jersey

Piscataway, New Jersey

 

Internal Medicine Clinical Pharmacist

Robert Wood Johnson University Hospital

New Brunswick, New Jersey

 

Faculty & Caregiver:

Ashley Ellis, PharmD, MBA, CDECS

ImPAcT Director & Assistant Professor

The University of Tennessee Health Science Center

Department of Clinical Pharmacy and Translation Science College of Pharmacy

Memphis, Tennessee

 

Mary Bridgeman, PharmD, BCPS, BCGP has no financial relationships with commercial interests to disclose.

Ashley Ellis, PharmD, MBA, CDECS, has the following financial relationships with commercial interests to disclose:

Grant/Research Support: Researcher AHRQ “Tennessee Heart Health Network” funding in form of salary release dollars

Consultant: Global Parents for Eczema Research, Continuing Education Alliance, McGraw Hill

 

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-0000-23-268-H01-P and 0290-0000-23-268-H01-T. The activity is available for CE credit through June 30, 2024.

This activity is supported by an educational grant from CeraVe and La Roche-Posay.

Brought to you in partnership with the National Eczema Association.